Fundies.
English

Segment disclosures

Company overview

PerkinElmer, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

105 dimension combinations 773 retained observations 17 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Applied Genomics · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:AppliedGenomicsMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-2952691000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29151425000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-3051287000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-3098734000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-3147447000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-0153434000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01175941000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-0259097000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02122507000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-0263410000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence

Applied Genomics · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:AppliedGenomicsMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-020 USD2024-05-07 · 22:05:49.000ZOpen filing evidence

Immunodiagnostics · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:ImmunodiagnosticsMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29197694000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29570631000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30197376000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30372937000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31175561000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31728486000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-01186281000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01532169000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02184995000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02345888000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02160893000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-011108737000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Immunodiagnostics · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:ImmunodiagnosticsMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-020 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Life Sciences Instruments · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-020 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Life Sciences Instruments · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-2978797000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29245959000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-3086252000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30167162000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-3180910000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31381262000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-0189658000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01285933000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02100101000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02196275000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-0296174000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01405554000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Life Sciences Reagents · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesReagentsMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-020 USD2024-05-07 · 22:05:49.000ZOpen filing evidence

Life Sciences Reagents · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesReagentsMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29178779000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29532856000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30176852000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30354077000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31177225000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-01171924000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01554010000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02192208000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02382086000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02189878000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence

Life Sciences Software · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesSoftwareMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-020 USD2024-05-07 · 22:05:49.000ZOpen filing evidence

Life Sciences Software · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesSoftwareMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-2943345000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29138990000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-3050743000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-3095645000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-3144902000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-0146273000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01132706000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-0244044000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-0286433000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-0242389000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence

Reproductive Health · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:ReproductiveHealthMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29132743000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29385793000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30129175000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30253050000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31123875000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-01123169000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01373911000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02128621000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02250742000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02122121000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence

Reproductive Health · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions pki:MajorGoodsserviceLinesAxis=pki:ReproductiveHealthMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-010 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-020 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-020 USD2024-05-07 · 22:05:49.000ZOpen filing evidence

Applied Markets · Diagnostics

Primaryendmarkets · Statement Business Segments

Source dimensions pki:PrimaryendmarketsAxis=pki:AppliedMarketsMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2022-04-04 – 2022-07-030 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-030 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Applied Markets · Discovery Analytical Solutions

Primaryendmarkets · Statement Business Segments

Source dimensions pki:PrimaryendmarketsAxis=pki:AppliedMarketsMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember
PeriodValueUnitFiledEvidence
2022-04-04 – 2022-07-03217887000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-03407844000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Diagnostics · Diagnostics

Primaryendmarkets · Statement Business Segments

Source dimensions pki:PrimaryendmarketsAxis=pki:DiagnosticsMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2023-07-03 – 2023-10-01362884000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-01-02 – 2023-10-011082021000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-01-02 – 2023-04-02346424000 USD2023-05-12 · 22:13:37.000ZOpen filing evidence
2022-07-04 – 2022-10-02399020000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-021625124000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-03569028000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-031226104000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Life Sciences · Diagnostics

Primaryendmarkets · Statement Business Segments

Source dimensions pki:PrimaryendmarketsAxis=pki:LifeSciencesMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2023-07-03 – 2023-10-010 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-01-02 – 2023-10-010 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-04-03 – 2023-07-020 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-07-02719137000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-04-020 USD2023-05-12 · 22:13:37.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2023-03-02 · 00:17:01.000ZOpen filing evidence
2022-07-04 – 2022-10-020 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-020 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-030 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-031226104000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Life Sciences · Discovery Analytical Solutions

Primaryendmarkets · Statement Business Segments

Source dimensions pki:PrimaryendmarketsAxis=pki:LifeSciencesMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-02312783000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02945484000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Life Sciences · Life Sciences

Primaryendmarkets · Statement Business Segments

Source dimensions pki:PrimaryendmarketsAxis=pki:LifeSciencesMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2023-07-03 – 2023-10-01307855000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-01-02 – 2023-10-01972649000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-04-03 – 2023-07-02336353000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-07-020 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-04-02328441000 USD2023-05-12 · 22:13:37.000ZOpen filing evidence
2022-07-04 – 2022-10-02312783000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02945484000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-03326614000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-030 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Reportable Segment Revenue · Diagnostics

Segment Reporting · Statement Business Segments

Source dimensions pki:SegmentReportingAxis=pki:ReportableSegmentRevenueMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29383333000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-291108470000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30378045000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30725137000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31347092000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-01363090000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-011082639000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02372919000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02719549000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02346630000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-07-04 – 2022-10-02399223000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-021625733000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-03569231000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-031226510000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Reportable Segment Revenue · Life Sciences

Segment Reporting · Statement Business Segments

Source dimensions pki:SegmentReportingAxis=pki:ReportableSegmentRevenueMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29300921000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29917805000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30313847000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30616884000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31303037000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-07-03 – 2023-10-01307855000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01972649000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02336353000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02664794000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02328441000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-04-04 – 2022-07-03326614000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-03632701000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Applied Genomics · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:AppliedGenomicsMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-29204760000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31228443000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01393602000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Applied Genomics · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:AppliedGenomicsMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-290 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Immunodiagnostics · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:ImmunodiagnosticsMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05214758000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05416589000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-05201831000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2025-06-30 – 2025-09-28212739000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28629119000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29218818000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29416380000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30197562000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-29772190000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2024-07-01 – 2024-09-29211566000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29613479000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30213252000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30401913000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2023-01-02 – 2023-12-31728486000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-011108737000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Immunodiagnostics · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:ImmunodiagnosticsMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-050 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-050 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-050 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2025-06-30 – 2025-09-280 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-280 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-290 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-290 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-300 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-290 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2024-07-01 – 2024-09-290 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Life Sciences Instruments · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-290 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Life Sciences Instruments · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-29334078000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31381262000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01405554000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Life Sciences Reagents · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesReagentsMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-290 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Life Sciences Reagents · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesReagentsMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-29719268000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31732789000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01691344000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Life Sciences Software · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesSoftwareMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-290 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Life Sciences Software · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesSoftwareMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-29200799000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31178289000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01196011000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Life Sciences Solutions · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-050 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-050 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-050 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2025-06-30 – 2025-09-280 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-280 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-290 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-290 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-300 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-07-01 – 2024-09-290 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2025-08-06 · 00:10:32.000ZOpen filing evidence

Life Sciences Solutions · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05301028000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05601024000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-05299996000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2025-06-30 – 2025-09-28290541000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28875046000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29298052000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29584505000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30286453000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-07-01 – 2024-09-29295455000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29884849000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30297782000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30589394000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence

Reproductive Health · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:ReproductiveHealthMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05156231000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05303673000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-05147442000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2025-06-30 – 2025-09-28143388000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28405761000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29135568000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29262373000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30126805000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-29523931000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2024-07-01 – 2024-09-29133683000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29388336000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30129908000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30254653000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2023-01-02 – 2023-12-31501302000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01516574000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Reproductive Health · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:ReproductiveHealthMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-050 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-050 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-050 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2025-06-30 – 2025-09-280 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-280 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-290 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-290 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-300 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-290 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2024-07-01 – 2024-09-290 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Software · Diagnostics

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:SoftwareMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-050 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-050 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-050 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2025-06-30 – 2025-09-280 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-280 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-290 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-290 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-300 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-07-01 – 2024-09-290 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-290 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-300 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-300 USD2025-08-06 · 00:10:32.000ZOpen filing evidence

Software · Life Sciences

Major Goodsservice Lines · Statement Business Segments

Source dimensions revv:MajorGoodsserviceLinesAxis=revv:SoftwareMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-0557671000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05119520000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-0561849000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2025-06-30 – 2025-09-2852281000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28174069000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-2967846000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29121788000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-3053942000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-07-01 – 2024-09-2943345000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29138990000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-3050743000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-3095645000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence

Reportable Segment Revenue · Diagnostics

Segment Reporting · Statement Business Segments

Source dimensions revv:SegmentReportingAxis=revv:ReportableSegmentRevenueMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05370989000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05720262000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-06-30 – 2025-09-28356127000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-281034880000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29354386000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29678753000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30324367000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-291500881000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2024-07-01 – 2024-09-29345249000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-291001815000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-03-31313406000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-311458231000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-012018913000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Reportable Segment Revenue · Life Sciences

Segment Reporting · Statement Business Segments

Source dimensions revv:SegmentReportingAxis=revv:ReportableSegmentRevenueMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05358699000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05720544000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-06-30 – 2025-09-28342822000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-281049115000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29365898000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29706293000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30340395000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-291254145000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2024-07-01 – 2024-09-29338800000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-291023839000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-03-31336514000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-311292340000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence
2022-01-03 – 2023-01-011292909000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Product · Diagnostics

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2022-04-04 – 2022-07-03354572000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-03812642000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Product · Discovery Analytical Solutions

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-02280115000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02846730000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Americas · Diagnostics

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29139254000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29416650000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30139370000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30277396000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31138026000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31543875000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-01133679000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01405885000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02134032000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02272206000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02138174000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01979473000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-02170478000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02824024000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-03325610000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-03653546000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Americas · Discovery Analytical Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-02165340000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02499419000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Americas · Life Sciences

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29163071000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29487812000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30168413000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30324741000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31156328000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31671738000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-01159916000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01508565000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02184795000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02348649000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02163854000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01683170000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-02165340000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02499419000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence

Americas · Diagnostics

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05142008000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05272449000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-05130441000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-28505104000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-06-30 – 2025-09-28129190000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28376049000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29126509000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29246859000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30120350000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-29477881000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-07-01 – 2024-09-29116849000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29352619000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30117993000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30235770000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-03-31117777000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31455831000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2022-01-03 – 2023-01-01979473000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Americas · Life Sciences

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05183575000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05369126000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-05185551000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-28750857000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-06-30 – 2025-09-28178087000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28559437000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29197071000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29381350000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30184279000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-29745206000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-07-01 – 2024-09-29185476000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29551843000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30189790000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30366367000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-03-31176577000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31759782000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2022-01-03 – 2023-01-01683170000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Asia · Diagnostics

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29129544000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29350722000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30121238000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30221178000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-3199940000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31475899000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-01123785000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01349194000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02121771000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02225409000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02103638000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01505097000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-02124617000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02382772000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-03127183000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-03258155000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Asia · Discovery Analytical Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember
PeriodValueUnitFiledEvidence
2022-04-04 – 2022-07-03198714000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-03369684000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Asia · Life Sciences

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-2970142000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29225282000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-3078076000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30155140000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-3177064000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31312035000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-0175301000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01236454000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-0276851000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02161153000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-0284302000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01312271000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-0275293000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02230671000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-0380674000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-03155379000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Asia · Diagnostics

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-0589418000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05176899000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-0587481000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-28438372000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-06-30 – 2025-09-28107872000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28314662000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29108543000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29206790000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-3098247000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-29451103000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-07-01 – 2024-09-29121477000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29331131000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30115131000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30209654000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-03-3194523000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31434238000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2022-01-03 – 2023-01-01505097000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Asia · Life Sciences

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AsiaMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-0585646000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05170245000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-0584599000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-28336740000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-06-30 – 2025-09-2881403000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28246026000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-2984529000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29164623000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-3080094000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-29338222000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-07-01 – 2024-09-2978209000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29244873000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-3084183000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30166664000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-03-3182481000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31353697000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2022-01-03 – 2023-01-01312271000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Europe · Diagnostics

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29114330000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29340477000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30117230000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30226147000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-07-03 – 2023-10-01105420000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01326942000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02116910000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02221522000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02104612000 USD2023-05-12 · 22:13:37.000ZOpen filing evidence
2022-01-03 – 2023-01-01534343000 USD2023-03-02 · 00:17:01.000ZOpen filing evidence
2022-07-04 – 2022-10-02103925000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02418328000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-03116235000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-03314403000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Europe · Discovery Analytical Solutions

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-0272150000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02215394000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Europe · Life Sciences

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-2967708000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29204711000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-3067358000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30137003000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-3169645000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31308567000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-0172638000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01227630000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-0274707000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02154992000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-0280285000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01297468000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-0272150000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02215394000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-0371658000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-03143243000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Europe · Diagnostics

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05139563000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05270914000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-05131351000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-28481471000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-06-30 – 2025-09-28119065000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28344169000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29119334000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29225104000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30105770000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-29427441000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-07-01 – 2024-09-29106923000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29318065000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30110036000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30211142000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-03-31101106000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31402310000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2022-01-03 – 2023-01-01534343000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Europe · Life Sciences

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-0589478000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05181173000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-0591695000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-28343507000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-06-30 – 2025-09-2883332000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-28243652000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-2984298000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29160320000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-3076022000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-29315173000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-07-01 – 2024-09-2975115000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-29227123000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-3074552000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30152008000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-03-3177456000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31344713000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2022-01-03 – 2023-01-01297468000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Customer Concentration Risk · Diagnostics

Concentration Risk By Type · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByTypeAxis=us-gaap:CustomerConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-0212000000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02301600000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-03176900000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-03289600000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Customer Concentration Risk · Diagnostics

Concentration Risk By Type · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByTypeAxis=us-gaap:CustomerConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-01330700000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Diagnostics

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29383128000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-291107849000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30377838000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30724721000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31346883000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-311458231000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-01362884000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-011082021000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02372713000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02719137000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02346424000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-012018913000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-02399020000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-021625124000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-04-04 – 2022-07-03569028000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-031226104000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Diagnostics · Applied Genomics

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;pki:MajorGoodsserviceLinesAxis=pki:AppliedGenomicsMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-31228443000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-01393602000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Diagnostics · Life Sciences Reagents

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesReagentsMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-310 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Diagnostics · Life Sciences Software

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesSoftwareMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-310 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Diagnostics · Reproductive Health

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;pki:MajorGoodsserviceLinesAxis=pki:ReproductiveHealthMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-31501302000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-01516574000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Diagnostics · Diagnostics

Statement Business Segments · Primaryendmarkets

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;pki:PrimaryendmarketsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2023-04-03 – 2023-07-02372713000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-07-020 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2023-01-012018913000 USD2023-03-02 · 00:17:01.000ZOpen filing evidence
2022-07-04 – 2022-10-02399020000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-021625124000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-04-04 – 2022-07-03569028000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-030 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Diagnostics · Life Sciences

Statement Business Segments · Primaryendmarkets

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;pki:PrimaryendmarketsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2022-04-04 – 2022-07-030 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-030 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Diagnostics · Reportable Segment Revenue

Statement Business Segments · Segment Reporting

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;pki:SegmentReportingAxis=pki:ReportableSegmentRevenueMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-311459058000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-012019727000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Diagnostics · Product

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-02325342000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-021137985000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Diagnostics · Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-0273678000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02487139000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-04-04 – 2022-07-03214456000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-03413462000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Diagnostics · Americas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;srt:StatementGeographicalAxis=srt:AmericasMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-01979473000 USD2023-03-02 · 00:17:01.000ZOpen filing evidence
2022-07-04 – 2022-10-02170478000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02824024000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-04-04 – 2022-07-03325610000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-03653546000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Diagnostics · Asia

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;srt:StatementGeographicalAxis=srt:AsiaMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-02124617000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02382772000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Diagnostics · Europe

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31108917000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-31438457000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-01-02 – 2023-04-02104612000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-01534343000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-02103925000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02418328000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Diagnostics · Customer Concentration Risk

Statement Business Segments · Concentration Risk By Type

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:CustomerConcentrationRiskMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-01330700000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-0212000000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02301600000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-04-04 – 2022-07-03176900000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2022-01-03 – 2022-07-03289600000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence

Diagnostics · Transferred At Point In Time

Statement Business Segments · Timing Of Transfer Of Good Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=us-gaap:TransferredAtPointInTimeMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-02358481000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-021418540000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-04-04 – 2022-07-03505539000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-031060059000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Diagnostics · Transferred Over Time

Statement Business Segments · Timing Of Transfer Of Good Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiagnosticsMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=us-gaap:TransferredOverTimeMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-0240539000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02206584000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Discovery Analytical Solutions

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-011292909000 USD2023-03-02 · 00:17:01.000ZOpen filing evidence
2022-07-04 – 2022-10-02312783000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02945484000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-04-04 – 2022-07-03660541000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-031262907000 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Discovery Analytical Solutions · Diagnostics

Statement Business Segments · Primaryendmarkets

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;pki:PrimaryendmarketsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-010 USD2023-03-02 · 00:17:01.000ZOpen filing evidence
2022-07-04 – 2022-10-020 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-020 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-04-04 – 2022-07-030 USD2022-08-09 · 22:08:59.000ZOpen filing evidence
2022-01-03 – 2022-07-030 USD2022-08-09 · 22:08:59.000ZOpen filing evidence

Discovery Analytical Solutions · Life Sciences

Statement Business Segments · Primaryendmarkets

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;pki:PrimaryendmarketsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-011292909000 USD2023-03-02 · 00:17:01.000ZOpen filing evidence

Discovery Analytical Solutions · Reportable Segment Revenue

Statement Business Segments · Segment Reporting

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;pki:SegmentReportingAxis=pki:ReportableSegmentRevenueMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-311292340000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-011292909000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Discovery Analytical Solutions · Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-0232668000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-0298754000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Discovery Analytical Solutions · Americas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;srt:StatementGeographicalAxis=srt:AmericasMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-01683170000 USD2023-03-02 · 00:17:01.000ZOpen filing evidence

Discovery Analytical Solutions · Asia

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;srt:StatementGeographicalAxis=srt:AsiaMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-01312271000 USD2023-03-02 · 00:17:01.000ZOpen filing evidence
2022-07-04 – 2022-10-0275293000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02230671000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Discovery Analytical Solutions · Europe

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2023-01-01297468000 USD2023-03-02 · 00:17:01.000ZOpen filing evidence

Discovery Analytical Solutions · Transferred At Point In Time

Statement Business Segments · Timing Of Transfer Of Good Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=us-gaap:TransferredAtPointInTimeMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-02279235000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-02847030000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Discovery Analytical Solutions · Transferred Over Time

Statement Business Segments · Timing Of Transfer Of Good Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:DiscoveryAnalyticalSolutionsMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=us-gaap:TransferredOverTimeMember
PeriodValueUnitFiledEvidence
2022-07-04 – 2022-10-0233548000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence
2022-01-03 – 2022-10-0298454000 USD2022-11-15 · 00:05:55.000ZOpen filing evidence

Life Sciences

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-29300921000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-01-01 – 2024-09-29917805000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2024-04-01 – 2024-06-30313847000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-06-30616884000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2024-01-01 – 2024-03-31303037000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2023-01-02 – 2023-12-311292340000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2023-07-03 – 2023-10-01307855000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-01-02 – 2023-10-01972649000 USD2024-11-07 · 02:13:11.000ZOpen filing evidence
2023-04-03 – 2023-07-02336353000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-07-02664794000 USD2024-08-07 · 00:09:24.000ZOpen filing evidence
2023-01-02 – 2023-04-02328441000 USD2024-05-07 · 22:05:49.000ZOpen filing evidence
2022-01-03 – 2023-01-011292909000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-07-04 – 2022-10-02312783000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02945484000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence

Life Sciences · Applied Genomics

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;pki:MajorGoodsserviceLinesAxis=pki:AppliedGenomicsMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-310 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Life Sciences · Life Sciences Reagents

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesReagentsMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-31732789000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-01691344000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Life Sciences · Life Sciences Software

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;pki:MajorGoodsserviceLinesAxis=pki:LifeSciencesSoftwareMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-31178289000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-01196011000 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Life Sciences · Reproductive Health

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;pki:MajorGoodsserviceLinesAxis=pki:ReproductiveHealthMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-12-310 USD2024-02-28 · 00:10:18.000ZOpen filing evidence
2022-01-03 – 2023-01-010 USD2024-02-28 · 00:10:18.000ZOpen filing evidence

Life Sciences · Diagnostics

Statement Business Segments · Primaryendmarkets

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;pki:PrimaryendmarketsAxis=pki:DiagnosticsMember
PeriodValueUnitFiledEvidence
2023-07-03 – 2023-10-010 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-01-02 – 2023-10-010 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-04-03 – 2023-07-020 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-07-02664794000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-04-020 USD2023-05-12 · 22:13:37.000ZOpen filing evidence
2022-07-04 – 2022-10-020 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-020 USD2023-11-08 · 00:08:04.000ZOpen filing evidence

Life Sciences · Reportable Segment Revenue

Statement Business Segments · Segment Reporting

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;pki:SegmentReportingAxis=pki:ReportableSegmentRevenueMember
PeriodValueUnitFiledEvidence
2023-07-03 – 2023-10-01307855000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-01-02 – 2023-10-01972649000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2023-01-02 – 2023-04-02328441000 USD2023-05-12 · 22:13:37.000ZOpen filing evidence
2022-07-04 – 2022-10-02312783000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence
2022-01-03 – 2022-10-02945484000 USD2023-11-08 · 00:08:04.000ZOpen filing evidence

Life Sciences · Americas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;srt:StatementGeographicalAxis=srt:AmericasMember
PeriodValueUnitFiledEvidence
2023-04-03 – 2023-07-02184795000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-07-02348649000 USD2023-08-09 · 21:48:15.000ZOpen filing evidence
2023-01-02 – 2023-04-02163854000 USD2023-05-12 · 22:13:37.000ZOpen filing evidence

Life Sciences · Asia

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;srt:StatementGeographicalAxis=srt:AsiaMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-04-0284302000 USD2023-05-12 · 22:13:37.000ZOpen filing evidence

Life Sciences · Europe

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pki:LifeSciencesMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2023-01-02 – 2023-04-0280285000 USD2023-05-12 · 22:13:37.000ZOpen filing evidence

Diagnostics

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05370989000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05720262000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-05349273000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-281424947000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-06-30 – 2025-09-28356127000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-281034880000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29354386000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29678753000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30324367000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-291356425000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-07-01 – 2024-09-29345249000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-291001815000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30343160000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30656566000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-03-31313406000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-311292379000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2022-01-03 – 2023-01-012018913000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Diagnostics · Immunodiagnostics

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember;revv:MajorGoodsserviceLinesAxis=revv:ImmunodiagnosticsMember
PeriodValueUnitFiledEvidence
2024-12-30 – 2025-12-28869908000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-12-30 – 2025-03-30197562000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-29828627000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-01-01 – 2024-03-31188661000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31787394000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Diagnostics · Life Sciences Solutions

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember;revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesSolutionsMember
PeriodValueUnitFiledEvidence
2024-12-30 – 2025-12-280 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-12-30 – 2025-03-300 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-290 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Diagnostics · Reproductive Health

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember;revv:MajorGoodsserviceLinesAxis=revv:ReproductiveHealthMember
PeriodValueUnitFiledEvidence
2024-12-30 – 2025-12-28555039000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-12-30 – 2025-03-30126805000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-29527798000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-01-01 – 2024-03-31124745000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31504985000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Diagnostics · Software

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember;revv:MajorGoodsserviceLinesAxis=revv:SoftwareMember
PeriodValueUnitFiledEvidence
2024-12-30 – 2025-12-280 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-12-30 – 2025-03-300 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-290 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Diagnostics · Reportable Segment Revenue

Statement Business Segments · Segment Reporting

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:DiagnosticsMember;revv:SegmentReportingAxis=revv:ReportableSegmentRevenueMember
PeriodValueUnitFiledEvidence
2025-12-29 – 2026-04-05349273000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-281424947000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-03-31 – 2025-06-29354386000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-12-30 – 2025-06-29678753000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-12-30 – 2025-03-30324367000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-291356425000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-04-01 – 2024-06-30343160000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30656566000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2023-01-02 – 2023-12-311292379000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Life Sciences

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember
PeriodValueUnitFiledEvidence
2026-04-06 – 2026-07-05358699000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-07-05720544000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2025-12-29 – 2026-04-05361845000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-281431104000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-06-30 – 2025-09-28342822000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-12-30 – 2025-09-281049115000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2025-03-31 – 2025-06-29365898000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-06-29706293000 USD2026-08-12 · 00:06:50.000ZOpen filing evidence
2024-12-30 – 2025-03-30340395000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-291398601000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-07-01 – 2024-09-29338800000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-01-01 – 2024-09-291023839000 USD2025-11-05 · 02:08:31.000ZOpen filing evidence
2024-04-01 – 2024-06-30348525000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30685039000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-03-31336514000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-311458192000 RestatedUSD2026-02-25 · 02:10:08.000ZOpen filing evidence
2022-01-03 – 2023-01-011292909000 USD2025-02-26 · 02:15:49.000ZOpen filing evidence

Life Sciences · Immunodiagnostics

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember;revv:MajorGoodsserviceLinesAxis=revv:ImmunodiagnosticsMember
PeriodValueUnitFiledEvidence
2024-12-30 – 2025-12-280 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-12-30 – 2025-03-300 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-290 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Life Sciences · Life Sciences Solutions

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember;revv:MajorGoodsserviceLinesAxis=revv:LifeSciencesSolutionsMember
PeriodValueUnitFiledEvidence
2024-12-30 – 2025-12-281194728000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-12-30 – 2025-03-30286453000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-291197802000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-01-01 – 2024-03-31291612000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-311279903000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Life Sciences · Reproductive Health

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember;revv:MajorGoodsserviceLinesAxis=revv:ReproductiveHealthMember
PeriodValueUnitFiledEvidence
2024-12-30 – 2025-12-280 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-12-30 – 2025-03-300 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-290 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-01-01 – 2024-03-310 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-310 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Life Sciences · Software

Statement Business Segments · Major Goodsservice Lines

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember;revv:MajorGoodsserviceLinesAxis=revv:SoftwareMember
PeriodValueUnitFiledEvidence
2024-12-30 – 2025-12-28236376000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-12-30 – 2025-03-3053942000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2024-01-01 – 2024-12-29200799000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-01-01 – 2024-03-3144902000 USD2025-05-07 · 00:07:57.000ZOpen filing evidence
2023-01-02 – 2023-12-31178289000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence

Life Sciences · Reportable Segment Revenue

Statement Business Segments · Segment Reporting

Source dimensions us-gaap:StatementBusinessSegmentsAxis=revv:LifeSciencesMember;revv:SegmentReportingAxis=revv:ReportableSegmentRevenueMember
PeriodValueUnitFiledEvidence
2025-12-29 – 2026-04-05361845000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-12-30 – 2025-12-281431104000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2025-03-31 – 2025-06-29365898000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-12-30 – 2025-06-29706293000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-12-30 – 2025-03-30340395000 USD2026-05-13 · 00:07:05.000ZOpen filing evidence
2024-01-01 – 2024-12-291398601000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence
2024-04-01 – 2024-06-30348525000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2024-01-01 – 2024-06-30685039000 USD2025-08-06 · 00:10:32.000ZOpen filing evidence
2023-01-02 – 2023-12-311458192000 USD2026-02-25 · 02:10:08.000ZOpen filing evidence